secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2024-02-23T23:59:59+00:00
Accession:  0001104659-24-027037
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics increases authorized common shares from 75M to 200M
-----------------------------------------------------------------------

- Stockholders approved via written consent on Jan 9, 2024 to increase authorized common shares from 75M to 200M.
- Certificate of Amendment filed with Delaware Secretary of State on Feb 20, 2024 effectuating the increase.
- No immediate share issuance; increase provides flexibility for future capital raising or strategic transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465924027037/0001104659-24-027037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465924027037/tm246865d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-027037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer